125 related articles for article (PubMed ID: 2843835)
1. [3H][D-Ala2,NMePhe4,Gly-ol5]-enkephalin (mu-opioid) binding in beige-J mice.
Raffa RB; Baldy WJ; Shank RP; Mathiasen JR; Vaught JL
Peptides; 1988; 9(3):637-42. PubMed ID: 2843835
[TBL] [Abstract][Full Text] [Related]
2. C57BL/6J-bgJ (beige) mice: differential sensitivity in the tail flick test to centrally administered mu- and delta-opioid receptor agonists.
Mathiasen JR; Raffa RB; Vaught JL
Life Sci; 1987 May; 40(20):1989-94. PubMed ID: 3033418
[TBL] [Abstract][Full Text] [Related]
3. Binding in vivo of selective mu and delta opioid receptor agonists: opioid receptor occupancy by endogenous enkephalins.
Meucci E; Delay-Goyet P; Roques BP; Zajac JM
Eur J Pharmacol; 1989 Nov; 171(2-3):167-78. PubMed ID: 2559856
[TBL] [Abstract][Full Text] [Related]
4. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
Vaught JL; Mathiasen JR; Raffa RB
J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533
[TBL] [Abstract][Full Text] [Related]
5. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
[TBL] [Abstract][Full Text] [Related]
6. Substance P modulation of [3H]DAGO binding in the brain of Swiss-Webster and CXBK (mu opioid receptor deficient) mice.
Krumins SA; Kim DC; Larson AA
Prog Clin Biol Res; 1990; 328():149-52. PubMed ID: 1689493
[No Abstract] [Full Text] [Related]
7. Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors.
Wang XJ; Han JS
J Neurochem; 1990 Oct; 55(4):1379-82. PubMed ID: 2168937
[TBL] [Abstract][Full Text] [Related]
8. Colonic bead expulsion time in normal and mu-opioid receptor deficient (CXBK) mice following central (ICV) administration of mu- and delta-opioid agonists.
Raffa RB; Mathiasen JR; Jacoby HI
Life Sci; 1987 Nov; 41(19):2229-34. PubMed ID: 2823042
[TBL] [Abstract][Full Text] [Related]
9. [3H]ohmefentanyl preferentially binds to mu-opioid receptors but also labels sigma-sites in rat brain sections.
Wang H; Pélaprat D; Roques BP; Vanhove A; Chi ZQ; Rostène W
Eur J Pharmacol; 1991 Feb; 193(3):341-50. PubMed ID: 1647320
[TBL] [Abstract][Full Text] [Related]
10. Analgesic effect of mu- and kappa-opioid agonists in beige and CXBK mice.
Muraki T; Oike N; Shibata Y; Nomoto T
J Pharm Pharmacol; 1991 Mar; 43(3):210-2. PubMed ID: 1675282
[TBL] [Abstract][Full Text] [Related]
11. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
12. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
Cruciani RA; Lutz RA; Munson PJ; Rodbard D
J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
[TBL] [Abstract][Full Text] [Related]
13. The use of [3H]-[D-Pen2,D-Pen5]enkephalin as a highly selective ligand for the delta-binding site.
Cotton R; Kosterlitz HW; Paterson SJ; Rance MJ; Traynor JR
Br J Pharmacol; 1985 Apr; 84(4):927-32. PubMed ID: 2988685
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the presence of mu- and kappa- but not of delta-opioid sites in the human fetal brain.
Magnan J; Tiberi M
Brain Res Dev Brain Res; 1989 Feb; 45(2):275-81. PubMed ID: 2540923
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation.
Yoburn BC; Sierra V; Lutfy K
Brain Res; 1990 Oct; 529(1-2):143-8. PubMed ID: 2178026
[TBL] [Abstract][Full Text] [Related]
16. Characterization of opioid receptors in cultured neurons.
Vaysse PJ; Zukin RS; Fields KL; Kessler JA
J Neurochem; 1990 Aug; 55(2):624-31. PubMed ID: 2164573
[TBL] [Abstract][Full Text] [Related]
17. 14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes.
Bidlack JM; Frey DK; Seyed-Mozaffari A; Archer S
Biochemistry; 1989 May; 28(10):4333-9. PubMed ID: 2548575
[TBL] [Abstract][Full Text] [Related]
18. Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites.
Rothman RB; Bykov V; Long JB; Brady LS; Jacobson AE; Rice KC; Holaday JW
Eur J Pharmacol; 1989 Jan; 160(1):71-82. PubMed ID: 2540993
[TBL] [Abstract][Full Text] [Related]
19. Characterization of opioid binding sites in murine neuroblastoma.
Zagon IS; Goodman SR; McLaughlin PJ
Brain Res; 1988 May; 449(1-2):80-8. PubMed ID: 2899449
[TBL] [Abstract][Full Text] [Related]
20. Tritiated-6-beta-fluoro-6-desoxy-oxymorphone ([3H]FOXY): a new ligand and photoaffinity probe for the mu opioid receptors.
Rothman RB; Bykov V; Rice KC; Jacobson AE; Kooper GN; Bowen WD
Neuropeptides; 1988 Jan; 11(1):1-6. PubMed ID: 2835700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
